Firm
Firms in Canada explain how they’ve adapted to a rule change in 2017 that has made advocacy skills more important in pharma disputes
Leaders at some IP businesses are looking to consolidate the fragmented market and, considering the benefits, their rivals may want to follow suit
Counsel at three US firms explain how they are expanding their UPC teams or if they are looking to partner with European firms
Lucy Wheatley, partner at McGuireWoods, discusses the challenges of explaining trademarks to a jury and reveals a logistical hurdle she had to navigate
Sponsored
Sponsored
-
Sponsored by CASCAS explains the five high-risk areas of IP for R&D organisations and identifies how companies can protect their innovations and safeguard their growth potential -
Sponsored by CASCAS shares how patent offices around the world are adopting AI, and explains the benefits of clean data, multiple algorithms, and leveraging human expertise alongside technology
-
Sponsored by CASThe CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation
-
Sponsored by CASPeter Blasi, business development manager at CAS IP Search, explains how to set standards for an effective IP search
-
Sponsored by CASAnne Marie Clark, senior patent searcher at CAS, looks at ways to protect and commercialise the promise of RNAi
-
Sponsored by CASCAS considers how the emerging field of RNA therapeutics highlights trends in targets, chemical modifications, and new delivery systems that increase stability of RNA
